Biosimilars Is Fastest Growing Segment Fueling The Growth Of Automated Cell Counters Market

https://www.coherentmarketinsights.com/industry-reports/automated-cell-counters-market
Automated Cell Counters Market 



Market Overview:

Automated cell counters are used for counting and analyzing cells in biological specimens such as blood, cerebrospinal fluid, sperm etc. Automated cell counters provide accurate and reproducible cell count results in a short period of time.

Market key trends:
One of the key trends in the automated cell counters market is the use of flow cytometry cell counting technology. Flow cytometry utilizes the principles of light scattering, light excitation, and fluorescence to obtain numerical data on physical and chemical characteristics of up to thousands of particles per second. Recent developments in flow cytometry technology have increased throughput and counting accuracy. Advancements in fluidics, optics, and computing capabilities have enabled high-speed cell counting for screening applications and improved analytical capabilities for identifying specific cell types based on biomarkers. This has expanded the use of automated cell counters in research areas such as immunology and stem cell research.

The global Automated Cell Counters Market Growth is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global automated cell counters market is segmented into product type, end user, and region. Based on product type, the market is segmented into spectrophotometers, hemocytometers, flow cytometers, and hematology analyzers. The flow cytometers segment held the largest market share in 2022 owing to its widespread use in clinical settings and research applications for cell counting and analysis.

Key Takeaways
The global automated cell counters market is expected to witness high growth, exhibiting a CAGR of 7.0% over the forecast period, due to increasing R&D investments in drug discovery and life sciences research.

The market size for automated cell counters is estimated to reach US$ 3.75 Bn by 2023.

North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to the presence of major players and availability of advanced healthcare technologies in the region. Asia Pacific is expected to witness the fastest growth rate owing to rising healthcare expenditure and increasing research activities in countries such as China and India.

Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan, and Sartorius AG. The major players are focusing on new product launches and expansions to garner a larger market share.

Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries